Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancerJames L. Gulley, Jeffrey Schlom, Vittore Cereda et al.|Cancer Immunology Immunotherapy|2009Cited by 298